The Latest Discovery by Dicerna Pharmaceuticals (NASDAQ:DRNA)
Por um escritor misterioso
Descrição
Next-Gen Partnerships: The Ascent of Advanced Therapies
Dicerna Pharmaceuticals Announces Move to Larger Office and Lab
Where Dicerna Pharmaceuticals Stands With Analysts
A Nano Drug Delivery IPO from Cerulean Pharma - Nanalyze
Drug Developers rise by 7% in 2021, led by Moderna and Dicerna
Dicerna Pharmaceuticals Inc (DRNA) Stock 5 Years History [Returns
Dicerna Bolsters Leadership Team to Support Continued Growth
Dicerna Soars 78.7% on Novo Nordisk's $3.3B Acquisition Offer
Alexion enters RNA gene-silencing field with $637M Dicerna deal
RNA Interference Technology Market [latest Reports] Business
Lilly and Dicerna Announce RNAi Licensing and Research
DRNA Stock Hits Stratosphere On $3.3 Billion Takeover
Novo Nordisk acquires Dicerna for USD 3.3bn — MedWatch
de
por adulto (o preço varia de acordo com o tamanho do grupo)
